Thursday, April 20, 2023
Oncotelic Therapeutics announced a strategic partnership with Vectara to accelerate the development of novel therapies for the treatment of cancer, infectious disease, and ageing.
The combination of Vectara's advanced NLU technology with internal AI discovery and development programmes will revolutionise drug discovery and development. This partnership represents a significant step forward for both companies, and anticipates the outcomes from this venture.
A LLM is an artificial intelligence (AI) system that uses deep learning algorithms to generate natural language from a large corpus of text. It is trained on a large text dataset and can generate new text similar to the original dataset. Large language models are used for a variety of tasks, such as natural language processing, text generation, and machine translation. LLMs such as ChatGPT took the world by storm forever changing how we do things.
The solution is expected to speed up pharmaceutical research to gain relevant and significantly robust results by accelerating the acquisition of insights, potentially leading to groundbreaking solutions for drug discovery and formulation.
One of the major challenges faced by scientists and researchers is the laborious and expensive process of sifting through massive research papers and publications to find valuable statistics or data points that could aid in the innovation and creation of new or improved immunotherapies. Publicly available artificial intelligence (AI) tools lack the required depth that subject matter experts need, despite their breadth in searching a large volume of data.
